Home > Protocol Summaries: Compounds > GSK376501 Protocol Summaries: GSK376501 GSKStudy ID Phase Title Status DIX109177 Phase 1 See Detailed Description Completed DIX109980 Phase 1 Phase I, Randomized, Open-Label, 3 Period Crossover Drug Interaction Study Between Simvastatin and GSK376501 in Healthy Subjects Completed DIX109981 Phase 1 A Single-Blind, Randomized, Placebo-Controlled, Ascending Single Dose and Repeat Dose Study with Once Daily Dosing To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK376501 in Healthy Overweight and Obese Subjects Completed DIX110825 Phase 1 A Single Center, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK376501 on Hepatic Cytochrome P450 Activity in Healthy Adult Subjects Completed
